Ahsan Aamir Ayub

Mr. Ahsan Aamir Ayub

University of Waterloo, School of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAhsan Aamir Ayub
Ahsan Aamir Ayub
SWShawn Wettig
Shawn Wettig
Drug delivery to the brain has been one of the toughest challenges researchers have faced to develop effective treatments for brain diseases. Owing to the blood–brain barrier (BBB), only a small portion of administered drug can reach the brain. A consequence of that is the need to administer a higher dose of the drug, which, expectedly, leads to a variety of unwanted side effects. Research in a variety of different fields has been underway for the past couple of decades to address this very serious and frequently lethal problem. One area of research that has produced optimistic results in recent years is nanomedicine. Nanomedicine is the science birthed by fusing the fields of nanotechnology, chemistry and medicine into one. Many different types of nanomedicine-based drug-delivery systems are currently being studied for the sole purpose of improved drug delivery to the brain. This review puts together and briefly summarizes some of the major breakthroughs in this crusade. Inorganic nanoparticle-based drug-delivery systems, such as gold nanoparticles and magnetic nanoparticles, are discussed, as well as some organic nanoparticulate systems. Amongst the organic drug-delivery nanosystems, polymeric micelles and dendrimers are discussed briefly and solid polymeric nanoparticles are explored in detail.

2 June 2021 in Chemistry of Materials
Verified
Journal Article
Closed access
FYFan Ye
Fan Ye
DCDarren Chang
Darren Chang
AAAhsan Aamir Ayub
Ahsan Aamir Ayub
KIKhaled Ibrahim
Khaled Ibrahim
ASAhmed Shahin
Ahmed Shahin
KMKevin P. Musselman
Kevin P. Musselman